Pathfinder Cell Therapy (Pathfinder Cell Therapy) Equity-to-Asset : -172.56 (As of Sep. 2015)

Pathfinder Cell Therapy Equity-to-Asset Chart

Pathfinder Cell Therapy Annual Data
	Trend	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14
Equity-to-Asset		Get a 7-Day Free Trial					-5.86	-1.10	-8.01	-29.36	-56.07

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Equity-to-Asset	Get a 7-Day Free Trial															-80.71	-56.07	-72.31	-131.45	-172.56

Competitive Comparison of Pathfinder Cell Therapy's Equity-to-Asset

For the Biotechnology subindustry, Pathfinder Cell Therapy's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pathfinder Cell Therapy's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pathfinder Cell Therapy's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Pathfinder Cell Therapy's Equity-to-Asset falls into.

Pathfinder Cell Therapy Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Pathfinder Cell Therapy's Equity to Asset Ratio for the fiscal year that ended in Dec. 2014 is calculated as

Pathfinder Cell Therapy's Equity to Asset Ratio for the quarter that ended in Sep. 2015 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pathfinder Cell Therapy  (OTCPK:PFND) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Pathfinder Cell Therapy Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description